The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

Demand for Apple’s Mac Mini has skyrocketed, particularly in China, as the small computer has become an ideal platform for experimenting with autonomous AI agents like OpenClaw and others. Now, a ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general malaise. Those symptoms, which typically resolve within days, are the natural ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. You might not be destined for a cubicle after all. As a number of big-name companies increase their ...

Remotely starting your car with an iPhone is an easy way to add comfort and efficiency to your routine. You might do so to pre-condition your vehicle during winter (so you can defrost the windshield ...

This is read by an automated voice. Please report any issues or inconsistencies here. Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective T reg cells. These cells help ensure that the ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

Across much of America, workers fear their options for remote work are slipping away. But remote work is alive and well, at least for now. Five years into the pandemic workplace revolution, roughly 38 ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...

RNA-LNP Based, Non-Viral Delivery - RNA-LNP delivery avoids genome integration risks, leaving no genetic footprint. Optimized for PBMCs - The only non-viral kit proven effective for PBMC reprogramming ...